ExodusPoint Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.23M | Buy |
190,567
+155,188
| +439% | +$6.7M | 0.07% | 255 |
|
2025
Q1 | $1.22M | Buy |
+35,379
| New | +$1.22M | 0.01% | 815 |
|
2024
Q3 | – | Sell |
-14,890
| Closed | -$377K | – | 1497 |
|
2024
Q2 | $377K | Buy |
+14,890
| New | +$377K | ﹤0.01% | 1144 |
|
2023
Q2 | – | Sell |
-12,624
| Closed | -$209K | – | 1760 |
|
2023
Q1 | $209K | Buy |
+12,624
| New | +$209K | ﹤0.01% | 1471 |
|
2022
Q4 | – | Sell |
-162,981
| Closed | -$1.62M | – | 1586 |
|
2022
Q3 | $1.62M | Sell |
162,981
-73,131
| -31% | -$727K | 0.02% | 867 |
|
2022
Q2 | $2.14M | Buy |
236,112
+143,854
| +156% | +$1.31M | 0.03% | 713 |
|
2022
Q1 | $936K | Buy |
+92,258
| New | +$936K | 0.01% | 1143 |
|
2021
Q4 | – | Sell |
-26,393
| Closed | -$1.24M | – | 2119 |
|
2021
Q3 | $1.24M | Buy |
+26,393
| New | +$1.24M | 0.02% | 888 |
|
2021
Q2 | – | Sell |
-10,889
| Closed | -$671K | – | 2263 |
|
2021
Q1 | $671K | Buy |
+10,889
| New | +$671K | 0.01% | 1114 |
|